Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Identification of a new oligomycin derivative as a specific inhibitor of the alternative peptidoglycan biosynthetic pathway

Abstract

Peptidoglycan is an important macromolecule in bacterial cell walls to maintain cell integrity, and its biosynthetic pathway has been well studied. Recently, we demonstrated that some bacteria such as Xanthomonas oryzae, a pathogen causing bacterial blight of rice, used an alternative pathway for peptidoglycan biosynthesis. In this pathway, MurD2, a MurD homolog, catalyzed the attachment of l-Glu to UDP-MurNAc-l-Ala and MurL, which did not show homology to any known protein, catalyzed epimerization of the terminal l-Glu of the MurD2 product to generate UDP-MurNAc-l-Ala-d-Glu. Because the alternative pathway also operates in some other plant pathogens and opportunistic pathogens, specific inhibitors of the alternative pathway could function as pesticides and antibiotics for these pathogens. In this study, we searched for specific inhibitors of the alternative pathway from metabolites produced by actinomycetes and identified a new oligomycin-class polyketide, which was revealed to inhibit the MurD2 reaction, in culture broth of Micromonospora sp. K18-0097.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

References

  1. van Heijenoort J. Recent advances in the formation of the bacterial peptidoglycan monomer unit. Nat Prod Rep. 2001;18:503–19.

    Article  PubMed  Google Scholar 

  2. El Zoeiby A, Sanschagrin F, Levesque RC. Structure and function of the Mur enzymes: development of novel inhibitors. Mol Microbiol. 2003;47:1–12.

    Article  PubMed  CAS  Google Scholar 

  3. Feng R, Satoh Y, Ogasawara Y, Yoshimura T, Dairi T. A glycopeptidyl-glutamate epimerase for bacterial peptidoglycan biosynthesis. J Am Chem Soc. 2017;139:4243–5.

    Article  PubMed  CAS  Google Scholar 

  4. Feng R, Satoh Y, Morita H, Ogasawara Y, Dairi T. Amino acid residues recognizing isomeric glutamate substrates in UDP-N-acetylmuramic acid-L-alanine-glutamate Synthetases. ACS Chem Biol. 2019;14:975–8.

    Article  PubMed  CAS  Google Scholar 

  5. Ogasawara Y, et al. Identification of actinomycin D as a specific inhibitor of the alternative pathway of peptidoglycan biosynthesis. J Antibiot. 2020;73:125–7.

    Article  CAS  Google Scholar 

  6. Fernandez-Chimeno RI, et al. IB-96212, a novel cytotoxic macrolide produced by a marine Micromonospora. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot. 2000;53:474–8.

    Article  CAS  Google Scholar 

  7. Canedo LM, Fernandez-Puentes JL, Baz JP. IB-96212, a novel cytotoxic macrolide produced by a marine Micromonospora. II. Physico-chemical properties and structure determination. J Antibiot. 2000;53:479–83.

    Article  CAS  Google Scholar 

  8. Lardy HA, Witonsky P, Johnson D. Antibiotics as Tools for Metabolic Studies. IV. Comparative Effectiveness of Oligomycins A, B, C, and Rutamycin as Inhibitors of Phosphoryl Transfer Reactions in Mitochondria. Biochemistry. 1965;4:552–4.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by Grants-in-Aid for Scientific Research from JSPS (JP22H04976 and JP18H03937) to TD and JP23H02145 and JP22H05130 to YO. We thank Robbie Lewis, MSc, from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Tohru Dairi or Yasushi Ogasawara.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Umetsu, S., Tsunoda, T., Kiyanagi, H. et al. Identification of a new oligomycin derivative as a specific inhibitor of the alternative peptidoglycan biosynthetic pathway. J Antibiot 77, 182–184 (2024). https://doi.org/10.1038/s41429-023-00693-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41429-023-00693-0

Search

Quick links